Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer

Giorgio Scagliotti, Thomas Brodowicz, Frances A. Shepherd, Christoph Zielinski, Johan Vansteenkiste, Christian Manegold, Lorinda Simms, Frank Fossella, Katherine Sugarman, Chandra P. Belani

Research output: Contribution to journalArticlepeer-review

190 Scopus citations

Fingerprint Dive into the research topics of 'Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences